Healthcare - Biotechnology - NASDAQ - US
$ 6.53
-8.16 %
$ 237 M
Market Cap
-1.62
P/E
Price Target
Average
164.71%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
12.05%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Biomea Fusion, Inc.
Wall Street analysts predict an average 1-year price target for BMEA of $17.3 , with forecasts ranging from a low of $5 to a high of $40 .
BMEA Lowest Price Target
Wall Street Target
5 USD
-23.43%
BMEA Average Price Target
Wall Street Target
17.3 USD
164.71%
BMEA Highest Price Target
Wall Street Target
40 USD
512.56%
REVENUE FORECAST
Revenue Forecast Chart BMEA
EBIT FORECAST
EBIT Forecast Chart BMEA
NET INCOME FORECAST
Net Income Chart BMEA